Azacitidine

From IDWiki
Revision as of 15:45, 24 February 2022 by Aidan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

References

  1. ^  Jason A. Trubiano, Michael Dickinson, Karin A. Thursky, Timothy Spelman, John F. Seymour, Monica A. Slavin, Leon J. Worth. Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes. Leukemia & Lymphoma. 2017;58(10):2379-2386. doi:10.1080/10428194.2017.1295141.